unknown
Stage
1
Investors
About
Vicore Pharma is a clinical-stage biopharmaceutical company developing AT2 receptor agonist therapies (notably C21) for the treatment of pulmonary and fibrotic diseases such as idiopathic pulmonary fibrosis and pulmonary arterial hypertension.
Explore Vicore Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.